93 related articles for article (PubMed ID: 11740638)
1. [Modification of mistletoe therapy to prevent epithelial tumors?].
Gabius HJ
Dtsch Med Wochenschr; 2001 Dec; 126(49):1415-6. PubMed ID: 11740638
[No Abstract] [Full Text] [Related]
2. [Value of mistletoe therapy in carcinoma patients].
Rostock M; Unger C
Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
[No Abstract] [Full Text] [Related]
3. [Mistletoe therapy. An alternative cancer treatment].
Ernst E
MMW Fortschr Med; 2000 Nov; 142(45):52-3. PubMed ID: 11107826
[No Abstract] [Full Text] [Related]
4. [Mistletoe in cancer treatment].
Umbreit D
Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S13-5. PubMed ID: 21452100
[No Abstract] [Full Text] [Related]
5. [Favorable long-term outcome with mistletoe therapy in a patient with centroblastic-centrocytic non hodgkin lymphoma].
Pierach CA
Dtsch Med Wochenschr; 2000 Aug; 125(31-32):958-60. PubMed ID: 10967963
[No Abstract] [Full Text] [Related]
6. [Oncologic mistletoe therapy--physicians' use and estimation of efficiency].
Stein GM
Dtsch Med Wochenschr; 2001 Jul; 126(28-29):833-4. PubMed ID: 11499270
[No Abstract] [Full Text] [Related]
7. [Favourable course of persisting malignant ascites].
Stange R; Jänsch A; Schrag S; Pflugbeil C; Schlodder D; Pandey-Hoffmann U; Uehleke B
Forsch Komplementmed; 2009 Feb; 16(1):49-53. PubMed ID: 19295230
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
9. Methodological artifacts in the assessment for (anti-) proliferative activities of mistletoe extracts.
Kelter G; Fiebig HH; Schierholz JM; Fischer IU
Pediatr Blood Cancer; 2007 Jul; 49(1):105; author reply 106. PubMed ID: 16830332
[No Abstract] [Full Text] [Related]
10. [Lectin compared to mistletoe use: experimental therapy form with preclinically verified risk potential].
Kuehn JJ; Kovacs E
Dtsch Med Wochenschr; 2002 Dec; 127(49):2637; author reply 2638. PubMed ID: 12469281
[No Abstract] [Full Text] [Related]
11. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant intravesical treatment of superficial bladder cancer with a standardized mistletoe extract.
Elsässer-Beile U; Leiber C; Wolf P; Lucht M; Mengs U; Wetterauer U
J Urol; 2005 Jul; 174(1):76-9. PubMed ID: 15947582
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of antibodies to the chitin-binding mistletoe lectin (cbML) in tumor patients before and during therapy with an aqueous mistletoe extract.
Klein R; Franz M; Wacker R; Classen K; Scheer R; Von Laue HB; Stoeva S; Voelter W
Eur J Med Res; 2004 Jun; 9(6):316-22. PubMed ID: 15257874
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of an unconventional treatment modality with mistletoe lectin to prevent recurrence of superficial bladder cancer: a randomized phase II trial.
Goebell PJ; Otto T; Suhr J; Rübben H
J Urol; 2002 Jul; 168(1):72-5. PubMed ID: 12050495
[TBL] [Abstract][Full Text] [Related]
15. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
16. [Mistletoe therapy is not consistent with good clinical practice].
Eckerdal G
Lakartidningen; 2014 Jan 29-Feb 4; 111(5):128-9. PubMed ID: 24624759
[No Abstract] [Full Text] [Related]
17. [Therapy with Cor-Vel liquid in pre-digitalization].
Chirstl G
Z Allgemeinmed; 1973 Jul; 49(19):938-9. PubMed ID: 4737972
[No Abstract] [Full Text] [Related]
18. Biological screening of Bangladeshi mango mistletoe bark extracts.
Islam R; Khurshid Alam AH; Hossain MA; Mosaddik MA; Sadik G
Fitoterapia; 2004 Jun; 75(3-4):405-8. PubMed ID: 15159008
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
Elsässer-Beile U; Leiber C; Wetterauer U; Bühler P; Wolf P; Lucht M; Mengs U
Anticancer Res; 2005; 25(6C):4733-6. PubMed ID: 16334168
[TBL] [Abstract][Full Text] [Related]
20. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
Grossarth-Maticek R; Ziegler R
Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
